Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 120 | 0 | 730 | 695 | 1,175 |
| Gross Profit | 120 | N/A | 730 | 695 | 1,175 |
| Operating Expenses | 87,274 | 73,617 | 64,587 | 63,434 | 57,202 |
| Operating Income | -87,154 | -73,617 | -63,857 | -62,739 | -56,027 |
| Other Income | 5,837 | 6,573 | 7,257 | 8,943 | 8,935 |
| Pre-tax Income | -81,317 | -67,044 | -56,600 | -53,796 | -47,092 |
| Net Income Continuous | -81,317 | -67,044 | -56,600 | -53,796 | -47,092 |
| Net Income | $-81,317 | $-67,044 | $-56,600 | $-53,796 | $-47,092 |
| EPS Basic Total Ops | -1.23 | -1.01 | -0.85 | -0.81 | -0.71 |
| EPS Basic Continuous Ops | -1.22 | -1.01 | -0.85 | -0.81 | -0.72 |
| EPS Diluted Total Ops | -1.23 | -1.01 | -0.85 | -0.81 | -0.71 |
| EPS Diluted Continuous Ops | -1.22 | -1.01 | -0.85 | -0.81 | -0.72 |
| EPS Diluted Before Non-Recurring Items | -1.22 | -1.01 | -0.85 | -0.81 | -0.71 |
| EBITDA(a) | $-87,220 | $-73,811 | $-64,672 | $-64,139 | $-58,571 |